Project Grant HT94252411064
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$617K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
The U.S. Department of the Army Medical Command has awarded a $577,383.00 Project Grant to The Children's Hospital Corporation, doing business as Boston Children's Hospital, under the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant, with a performance period from September 1, 2024 to August 31, 2027, will support the hospital's research to develop base editing techniques to improve conditioning and transplantation of bone marrow failure patients. As a...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,416,000 Project Grant to The Children's Hospital Corporation (Boston Children's Hospital), a non-profit teaching hospital and research center affiliated with Harvard Medical School. The grant, titled "IND-ENABLING STUDIES OF POLYMERASE INHIBITORS FOR BMF DUE TO TELOMERE EXHAUSTION", will support a 2-year research project from Sep 1, 2023 to Aug 31, 2025. Through this funding, Boston...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $796,500 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to investigate clonal evolution in Fanconi anemia. The grant period runs from September 30, 2023 to September 29, 2026. As a non-profit pediatric teaching hospital and research center, Boston Children's Hospital will leverage its expertise in pediatric medicine, genomics, and...
This Project Grant award, valued at $3,062,579.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The award will support an integrated research approach to identify biopsychosocial aspects of pain in individuals with fibrous dysplasia/McCune-Albright syndrome over a period of 4 years, from April 2025 to April 2029. As a premier pediatric...
The Department of Defense's Defense Health Agency has awarded a $1,258,719 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The grant, awarded on July 15, 2024, will support a 3-year research project titled "Melanoma Chemoprevention via Neuropilin-2 Axis Blockade." Through this grant, Boston Children's Hospital will conduct biomedical research focused on...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $177,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund a project to develop a nanoparticle-based CRISPR screen to identify genetic regulators of chemoresistance. The screen will be used to investigate medical solutions for the battlefield by transforming health care for service members and the public...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $777,927 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will support research into targeting PARP signaling as a novel treatment for urologic complications of spinal cord injury from August 15, 2023 through August 14, 2026. The Military Medical Research and Development program aims to advance biomedical solutions for battlefield...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,068,000.00 to The Children's Hospital Corporation, doing business as Boston Children's Hospital, to conduct research on activating gasdermin pores to induce pyroptosis and antitumor immunity in ovarian cancers. The award period is from Apr 15, 2025 to Apr 14, 2028. Boston Children's Hospital, a premier pediatric medical research and teaching institution...
The Department of the Army Medical Command awarded a $1,416,000 project grant to Boston Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to define leukemia stem cells in acute lymphoblastic leukemia from September 2021 through September 2025. Through this funding, Boston Children's Hospital researchers will investigate medical solutions for the battlefield by transforming healthcare for service members and the public. The...
The Department of the Army Medical Command awarded a $711,403 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) under the Military Medical Research and Development program (CFDA 12.420). The grant supports a project titled "A Noninvasive Neurotrophic Factor Treatment to Repair the Injured Spinal Cord" with a period of performance from October 1, 2024 to September 30, 2027. This project grant supports advanced biomedical research focused...